BRAINSTORM CELL THERAPEUTICS INC. Stockholders' Equity Note, Stock Split, Conversion Ratio
Financial Statements › Balance Sheet › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-03-31
- BRAINSTORM CELL THERAPEUTICS INC. stockholders' equity note, stock split, conversion ratio for the quarter ending 2025-03-31 was 6.70%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month |
|---|---|---|---|---|
| 2025-09-30 | 6.70% 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 6.70% 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 6.70% 10-Q · filed 2025-05-15 | |||
| 2024-09-30 | 6.70% 10-K · filed 2026-03-31 | 6.70% 10-Q · filed 2024-11-14 |